ReeNT Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.79M
- Investors
-
6
ReeNT General Information
Description
Developer of regenerative medicine designed to provide a new system for intractable diseases in the ear, nose, and throat. The company specializes in otorhinolaryngology by developing cell sheets from patients' noses that can be transplanted into the middle ear after surgery for ventilation, enabling patients to get treatments for middle ear cholesteatoma and hearing loss.
Contact Information
Website
www.reent.co.jpCorporate Office
- 3-25-8, Nishi-Shinbashi
- Minato-ku
- Tokyo, 105-0003
- Japan
Corporate Office
- 3-25-8, Nishi-Shinbashi
- Minato-ku
- Tokyo, 105-0003
- Japan
ReeNT Timeline
ReeNT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 27-May-2026 | $3.79M | Completed | Generating Revenue | ||
| 5. Early Stage VC | 30-Dec-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 21-Oct-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 27-Aug-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ReeNT Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alfresa Holdings | Corporation | Minority | ||
| Intellectual Property Acceleration Program for Startups | Accelerator/Incubator | |||
| Mitsubishi UFJ Capital | Venture Capital | Minority | ||
| Nissay Capital | Venture Capital | Minority | ||
| Kawasaki Deep Tech Accelerator | Accelerator/Incubator |
ReeNT FAQs
-
When was ReeNT founded?
ReeNT was founded in 2021.
-
Where is ReeNT headquartered?
ReeNT is headquartered in Tokyo, Japan.
-
What industry is ReeNT in?
ReeNT’s primary industry is Drug Discovery.
-
Is ReeNT a private or public company?
ReeNT is a Private company.
-
What is ReeNT’s current revenue?
The current revenue for ReeNT is .
-
How much funding has ReeNT raised over time?
ReeNT has raised $3.79M.
-
Who are ReeNT’s investors?
Alfresa Holdings, Intellectual Property Acceleration Program for Startups, Mitsubishi UFJ Capital, Nissay Capital, and Kawasaki Deep Tech Accelerator are 5 of 6 investors who have invested in ReeNT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process